Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: The clinicopathological characteristics of POLE-mutated/ultramutated endometrial carcinoma and prognostic value of POLE status: a meta-analysis based on 49 articles incorporating 12,120 patients

Fig. 3

Forest plot of the meta-analysis estimating the hazard ratio (HR) with 95% confidence interval (CI) of a overall survival (OS), b progression free survival (PFS), c disease specific survival (DSS), and d relapse free survival (RFS) for POLEmut compared with POLE-wild-type (POLEwt) EC patients

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us